MX380217B - Agonistas del receptor cxcr3. - Google Patents
Agonistas del receptor cxcr3.Info
- Publication number
- MX380217B MX380217B MX2019002166A MX2019002166A MX380217B MX 380217 B MX380217 B MX 380217B MX 2019002166 A MX2019002166 A MX 2019002166A MX 2019002166 A MX2019002166 A MX 2019002166A MX 380217 B MX380217 B MX 380217B
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- receptor agonists
- cxcr3 receptor
- compounds
- cxcr3
- Prior art date
Links
- 108010061300 CXCR3 Receptors Proteins 0.000 title 1
- 102000011963 CXCR3 Receptors Human genes 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383202P | 2016-09-02 | 2016-09-02 | |
| US201762478496P | 2017-03-29 | 2017-03-29 | |
| PCT/US2017/049768 WO2018045246A1 (en) | 2016-09-02 | 2017-08-31 | Cxcr3 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019002166A MX2019002166A (es) | 2019-06-12 |
| MX380217B true MX380217B (es) | 2025-03-12 |
Family
ID=59846729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019002166A MX380217B (es) | 2016-09-02 | 2017-08-31 | Agonistas del receptor cxcr3. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190345133A1 (OSRAM) |
| EP (1) | EP3507275B1 (OSRAM) |
| JP (1) | JP7181857B2 (OSRAM) |
| AU (1) | AU2017318674B2 (OSRAM) |
| CA (1) | CA3034108A1 (OSRAM) |
| ES (1) | ES2950560T3 (OSRAM) |
| MX (1) | MX380217B (OSRAM) |
| WO (1) | WO2018045246A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4103223A4 (en) | 2020-02-12 | 2024-05-29 | The Regents of the University of California | PLATELET FACTORS AND COGNITIVE IMPROVEMENT |
| CN111943823A (zh) * | 2020-09-16 | 2020-11-17 | 安徽工业大学 | 一种苯菌酮的制备方法 |
| CN116178383B (zh) * | 2022-12-26 | 2025-04-22 | 南方科技大学 | 生物碱及三价铁卟啉催化合成生物碱的方法 |
-
2017
- 2017-08-31 ES ES17765033T patent/ES2950560T3/es active Active
- 2017-08-31 JP JP2019512307A patent/JP7181857B2/ja active Active
- 2017-08-31 MX MX2019002166A patent/MX380217B/es unknown
- 2017-08-31 WO PCT/US2017/049768 patent/WO2018045246A1/en not_active Ceased
- 2017-08-31 AU AU2017318674A patent/AU2017318674B2/en not_active Ceased
- 2017-08-31 US US16/335,641 patent/US20190345133A1/en not_active Abandoned
- 2017-08-31 CA CA3034108A patent/CA3034108A1/en not_active Abandoned
- 2017-08-31 EP EP17765033.0A patent/EP3507275B1/en active Active
-
2020
- 2020-05-11 US US16/872,161 patent/US11040954B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7181857B2 (ja) | 2022-12-01 |
| US20190345133A1 (en) | 2019-11-14 |
| MX2019002166A (es) | 2019-06-12 |
| JP2019533639A (ja) | 2019-11-21 |
| WO2018045246A1 (en) | 2018-03-08 |
| CA3034108A1 (en) | 2018-03-08 |
| ES2950560T3 (es) | 2023-10-11 |
| US11040954B1 (en) | 2021-06-22 |
| AU2017318674A1 (en) | 2019-03-28 |
| EP3507275B1 (en) | 2023-04-26 |
| AU2017318674B2 (en) | 2020-11-12 |
| EP3507275A1 (en) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125110T1 (el) | Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4 | |
| CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
| CL2016002148A1 (es) | Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos. | |
| CY1121413T1 (el) | Διυδροπυρρολοπυριδινης αναστολεις ror-γαμμα | |
| MX2019001096A (es) | Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos. | |
| CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
| CL2018001230A1 (es) | Tratamiento de osteoartritis | |
| DOP2015000270A (es) | Potenciador de inhibidores del homólogo de zeste | |
| MX377916B (es) | Compuestos 4-amino-imidazoquinolina. | |
| MX384752B (es) | ANTAGONISTAS SOLUBLES DE RECEPTOR DE C5a (C5aR). | |
| MX376062B (es) | Agonistas del receptor muscarinico. | |
| MX373247B (es) | Nuevos derivados de octahidro-pirrolo[3,4-c]-pirrol y análogos del mismo como inhibidores de atotaxina. | |
| MX381160B (es) | Agonistas del receptor de apelina y metodos de uso. | |
| MX380777B (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7. | |
| EA201791563A1 (ru) | Замещенные нуклеозидные производные, полезные в качестве агентов против рака | |
| EA201600091A1 (ru) | 4-членные кольцевые карбоксамиды, применяемые в качестве нематоцидов | |
| EA202091477A1 (ru) | Замещенные соединения простых индольных эфиров | |
| EA201891336A1 (ru) | Гетероарилгидроксипиримидиноны в качестве агонистов рецептора apj | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| MX376283B (es) | Compuestos de imidazopiridazina. | |
| MY192425A (en) | Polymorphs | |
| MX376414B (es) | Derivados de fenilo como agonistas del receptor de canabinoides 2. | |
| CY1123880T1 (el) | Καινοτομοι 5-ητ2 ανταγωνιστες | |
| JOP20200110A1 (ar) | متبلورات مضادة جديدة لسلسلة من مركبات مضادة للفيروسات |